返回
Swedish Orphan Biovitrum AB (publ) (BIOVF) 财务
BIOVF 股价走势图
BIOVF 财务
Swedish Orphan Biovitrum AB (publ)
$41.32
0%
$0
收盘价：Mar 26, 16:00:00 GMT-4
$41.32
0%
$0
盘前：Mar 27, 04:15:23 GMT-4
关键数据
前收盘价
$41.32
开盘价
$41.32
当日区间
$41.32 - $41.32
52周范围
$25.79 - $42.21
交易量
100
平均成交量
15
股息收益率
--
每股收益（TTM）
0.15
市值
$14.7B
什么是 SWEDISH ORPHAN BIOVITRUM AB？
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Stockholm, Stockholm and currently employs 1,888 full-time employees. The company went IPO on 2006-09-15. The firm develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The firm has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.